Haematinics. II. Clinical pharmacological and therapeutic aspects.
D000747:Anemia, Hypochromic / Q000188:drug therapy; D004304:Dosage Forms; D004338:Drug Combinations; D004339:Drug Compounding; D005492:Folic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005494:Folic Acid Deficiency / Q000188:drug therapy; D006410:Hematopoiesis; D006432:Hemochromatosis / Q000139:chemically induced; D006801:Humans; D007263:Infusions, Parenteral; D007501:Iron / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014805:Vitamin B 12 / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014806:Vitamin B 12 Deficiency / Q000188:drug therapy
D004304:Dosage Forms; D004338:Drug Combinations; D005492:Folic Acid; D007501:Iron; D014805:Vitamin B 12